TSPY1 and prostate carcinoma: Additional studies have demonstrated that TSPY is also expressed in prostate cancers and the androgen responsive LNCaP prostate cancer cell line [9,26], hepatoma specimens [30], and melanoma samples and melanoma cell lines [29].